Syed Shahzad Hasan

InstitutionUniversity of Huddersfield
AddressHuddersfield
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 86 Covid-19 publications, with a maximum of 11 publications in Spetember 2020
    All Publications
    Bar chart showing 115 publications over 14 distinct years, with a maximum of 50 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kow CS, Hasan SS. Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity. Eur J Prev Cardiol. 2022 02 09; 28(18):e52. PMID: 33624070.
      Citations:    Fields:    
    2. Kow CS, Hasan SS. Corticosteroid-related In-Hospital Hyperglycemia: Does It Negate Mortality Benefits in Coronavirus Disease 2019? Clin Infect Dis. 2021 11 02; 73(9):e2848-e2849. PMID: 32948881.
      Citations: 3     Fields:    Translation:Humans
    3. Kow CS, Hasan SS. The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2021 Aug 03. PMID: 34341972.
      Citations: 2     Fields:    
    4. Siddiqui A, Ahmed A, Tanveer M, Saqlain M, Kow CS, Hasan SS. An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan. Vaccine. 2021 08 31; 39(37):5251-5253. PMID: 34364719.
      Citations:    Fields:    Translation:Humans
    5. Thiruchelvam K, Kow CS, Hadi MA, Hasan SS. The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229. PMID: 34192469.
      Citations:    Fields:    
    6. Thiruchelvam K, Byles J, Hasan SS, Kairuz T. Innovating medication reviews through a technology-enabled process. Res Social Adm Pharm. 2022 04; 18(4):2700-2705. PMID: 34326004.
      Citations:    Fields:    
    7. Kow CS, Hasan SS. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies. Inflammopharmacology. 2021 Aug; 29(4):1075-1090. PMID: 34241782.
      Citations: 4     Fields:    Translation:Humans
    8. Hasan SS, Kow CS, Mustafa ZU, Merchant HA. Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials. Expert Rev Respir Med. 2021 08; 15(8):1049-1055. PMID: 33945381.
      Citations: 1     Fields:    Translation:Humans
    9. Kow CS, Hasan SS. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 07 01; 73(1):164-165. PMID: 32770237.
      Citations:    Fields:    Translation:Humans
    10. Ul Mustafa Z, Salman M, Aldeyab M, Kow CS, Hasan SS. Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. SN Compr Clin Med. 2021 May 28; 1-5. PMID: 34095752.
      Citations: 2     
    11. Kow CS, Ming LC, Hasan SS. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045. PMID: 34017093.
      Citations: 2     Fields:    Translation:Humans
    12. Kow CS, Merchant HA, Hasan SS. Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK. J Infect. 2021 07; 83(1):e14-e15. PMID: 33992685.
      Citations: 3     Fields:    Translation:Humans
    13. Kow CS, Hasan SS. Cerebral Venous Thrombosis following COVID-19 Vaccination. J Stroke Cerebrovasc Dis. 2021 10; 30(10):105866. PMID: 34045111.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Kow CS, Hasan SS. Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One. Chest. 2021 05; 159(5):2108-2109. PMID: 33965134.
      Citations:    Fields:    Translation:Humans
    15. Kow CS, Hasan SS. Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury. Int Braz J Urol. 2021 May-Jun; 47(3):690-691. PMID: 33621028.
      Citations:    Fields:    Translation:Humans
    16. Kow CS, Hasan SS. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology. 2021 Jun; 29(3):641-644. PMID: 33881684.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    17. Kow CS, Hasan SS. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis. 2021 Jul; 52(1):124-129. PMID: 33813716.
      Citations: 3     Fields:    Translation:Humans
    18. Kow CS, Merchant HA, Mustafa ZU, Hasan SS. The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479. PMID: 33779964.
      Citations: 7     Fields:    Translation:Humans
    19. Kow CS, Hasan SS. Do sleep quality and sleep duration before or after COVID-19 vaccination affect antibody response? Chronobiol Int. 2021 07; 38(7):941-943. PMID: 33771061.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    20. Rabeea SA, Merchant HA, Khan MU, Kow CS, Hasan SS. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021 Jun; 29(1):217-221. PMID: 33715138.
      Citations: 3     Fields:    Translation:Humans
    21. Kow CS, Abdul Sattar Burud I, Hasan SS. Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1365-1367. PMID: 33958065.
      Citations: 1     Fields:    Translation:Humans
    22. Mustafa ZU, Kow CS, Hasan SS. Effect of COVID-19 on viral hepatitis services in Pakistan. Lancet Gastroenterol Hepatol. 2021 03; 6(3):163-164. PMID: 33581756.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    23. Merchant HA, Kow CS, Hasan SS. COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021 08; 15(8):973-978. PMID: 33573416.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    24. Kow CS, Hasan SS. Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes. Endocr Res. 2021 Feb-May; 46(2):51-52. PMID: 33635726.
      Citations:    Fields:    Translation:Humans
    25. Kow CS, Hasan SS. Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19: a meta-analysis. J Asthma. 2021 Feb 08; 1-4. PMID: 33461348.
      Citations: 3     Fields:    
    26. Kow CS, Hasan SS. Potential interactions between COVID-19 vaccines and antiepileptic drugs. Seizure. 2021 03; 86:80-81. PMID: 33578259.
      Citations: 4     Fields:    Translation:Humans
    27. Kow CS, Hasan SS. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021 Aug; 77(8):1089-1094. PMID: 33532896.
      Citations: 6     Fields:    Translation:Humans
    28. El-Shimy IA, Mohamed MMA, Hasan SS, Hadi MA. Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. Pharmacol Res Perspect. 2021 02; 9(1):e00698. PMID: 33369210.
      Citations: 1     Fields:    Translation:Humans
    29. Kow CS, Hasan SS. Interferon-based therapies in COVID-19. Int Immunopharmacol. 2021 Apr; 93:107415. PMID: 33540249.
      Citations: 2     Fields:    Translation:Humans
    30. Kow CS, Hasan SS. Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19. Rheumatol Int. 2021 03; 41(3):677-678. PMID: 33388902.
      Citations: 4     Fields:    Translation:Humans
    31. Kow CS, Hasan SS. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic. Obes Surg. 2021 01; 31(1):413-414. PMID: 32583299.
      Citations:    Fields:    Translation:HumansPHPublic Health
    32. Kow CS, Hasan SS. Pharmacologic therapeutic options for thromboprophylaxis in COVID-19. J Thromb Thrombolysis. 2021 Jan; 51(1):29-30. PMID: 32596786.
      Citations:    Fields:    Translation:Humans
    33. Kow CS, Hasan SS. Persistent fatigue in patients with COVID-19. Clin Med (Lond). 2021 01; 21(1):e117. PMID: 33479096.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    34. Kow CS, Hasan SS. A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):361-364. PMID: 33423787.
      Citations: 4     Fields:    Translation:Humans
    35. Kow CS, Hasan SS. Optimal time for the resumption of biologics after COVID-19. JAAD Int. 2020 Dec; 1(2):189. PMID: 34173559.
      Citations:    
    36. Kow CS, Hasan SS, Hasan SS, Thiruchelvam K, Aldeyab M. Association of frailty and mortality in patients with COVID-19: a meta-analysis. Br J Anaesth. 2021 03; 126(3):e108-e110. PMID: 33358046.
      Citations: 6     Fields:    Translation:Humans
    37. Kow CS, Mustafa ZU, Hasan SS. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2021 02; 26(1):85-86. PMID: 33245006.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    38. Kow CS, Hasan SS. Use of Pharmacologic Agents With Weight Gain Potential for Panic Disorder Amid the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 11 25; 22(6). PMID: 33252868.
      Citations:    Fields:    Translation:HumansPHPublic Health
    39. Kow CS, Hasan SS. Dexamethasone or hydrocortisone in COVID-19? Cleve Clin J Med. 2020 11 23; 87(12):715. PMID: 33229384.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    40. Kow CS, Hasan SS. Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications. Card Fail Rev. 2020 Mar; 6:e32. PMID: 33552557.
      Citations:    
    41. Kow CS, Hasan SS. Use of DPP-4 inhibitors in patients with COVID-19. Acta Diabetol. 2021 02; 58(2):245-246. PMID: 33201345.
      Citations: 2     Fields:    
    42. Kow CS, Hasan SS. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100. PMID: 33112190.
      Citations:    Fields:    Translation:HumansPHPublic Health
    43. Kow CS, Aldeyab M, Hasan SS. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021 04; 93(4):1860-1861. PMID: 33118617.
      Citations: 2     Fields:    Translation:Humans
    44. Kow CS, Hasan SS, Hasan SS. Prochlorperazine for nausea and vomiting accompanied COVID-19. J Gastroenterol Hepatol. 2021 Feb; 36(2):524-525. PMID: 33068035.
      Citations: 1     Fields:    Translation:Humans
    45. Kow CS, Hasan SS. Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis. Am J Trop Med Hyg. 2020 11; 103(5):2149. PMID: 33236708.
      Citations:    Fields:    Translation:HumansPHPublic Health
    46. Hasan SS, Radford S, Kow CS, Zaidi STR. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):814-821. PMID: 32748122.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    47. Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240. PMID: 33054481.
      Citations: 3     Fields:    Translation:Humans
    48. Neill C, Sartaj M, Holcroft L, Hasan SS, Conway BR, Aldeyab MA. Surveillance study of asymptomatic and presymptomatic coronavirus disease 2019 (COVID-19) in care homes in Northern Ireland. Infect Control Hosp Epidemiol. 2021 11; 42(11):1400-1402. PMID: 33077002.
      Citations: 3     Fields:    Translation:Humans
    49. Kow CS, Hasan SS, Hasan SS. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis. J Intern Med. 2021 01; 289(1):125-128. PMID: 33078881.
      Citations: 8     Fields:    Translation:Humans
    50. Kow CS, Hasan SS. Macrolides for patients with COVID-19 and concurrent pertussis infection. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115245. PMID: 33130501.
      Citations:    Fields:    Translation:Humans
    51. Kow CS, Hasan SS. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118. PMID: 33044704.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    52. Kow CS, Aldeyab M, Hasan SS. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437. PMID: 33011825.
      Citations: 4     Fields:    Translation:Humans
    53. Kow CS, Capstick T, Hasan SS. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy. 2021 03; 76(3):959-960. PMID: 33006777.
      Citations: 5     Fields:    Translation:Humans
    54. Kow CS, Hasan SS. The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic. Headache. 2020 10; 60(9):2085-2086. PMID: 32790208.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    55. Kow CS, Hasan SS. Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020 10; 40(10):989-990. PMID: 32816219.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    56. Kow CS, Hasan SS. Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol. 2021 02; 93(2):695-697. PMID: 32902868.
      Citations: 22     Fields:    Translation:Humans
    57. Kow CS, Hasan SS. [Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19]. Rev Esp Cardiol. 2021 Feb; 74(2):200-201. PMID: 33012950.
      Citations:    Fields:    
    58. Mazhar F, Hadi MA, Kow CS, Marran AMN, Merchant HA, Hasan SS. Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120. PMID: 33007453.
      Citations: 1     Fields:    Translation:Humans
    59. Kow CS, Hasan SS. Azithromycin in patients with COVID-19: Friend or foe? Clin Microbiol Infect. 2021 01; 27(1):136-137. PMID: 33007473.
      Citations: 3     Fields:    Translation:Humans
    60. Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, Zaidi STR. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163. PMID: 32734777.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    61. Kow CS, Hasan SS. The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035. PMID: 32692903.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    62. Kow CS, Hasan SS. [The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19]. Rev Esp Cardiol. 2021 Jan; 74(1):114-115. PMID: 32989336.
      Citations: 1     Fields:    
    63. Kow CS, Hasan SS. Revascularization in COVID-19 patients with renal infarction. Am J Transplant. 2021 03; 21(3):1345. PMID: 32886860.
      Citations:    Fields:    Translation:Humans
    64. Kow CS, Hasan SS. The use of antimotility drugs in COVID-19 associated diarrhea. J Infect. 2021 02; 82(2):e19. PMID: 32956731.
      Citations: 2     Fields:    Translation:Humans
    65. Kow CS, Hasan SS. Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Rev Esp Cardiol (Engl Ed). 2021 02; 74(2):200-201. PMID: 32962968.
      Citations:    Fields:    Translation:Humans
    66. Hasan SS, Kow CS, Hadi MA, Zaidi STR, Merchant HA. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590. PMID: 32918209.
      Citations: 6     Fields:    Translation:Humans
    67. Kow CS, Hasan SS. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol (Engl Ed). 2021 01; 74(1):114-115. PMID: 32933883.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    68. Kow CS, Hasan SS. Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers. Drugs Ther Perspect. 2020 Aug 16; 1-5. PMID: 32837197.
      Citations: 1     
    69. Akhtar S, Benter IF, Danjuma MI, Doi SAR, Hasan SS, Hasan SS, Habib AM. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target. 2020 Aug-Sep; 28(7-8):683-699. PMID: 32700580.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    70. Kow CS, Hasan SS. Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020 11 01; 134:153-155. PMID: 32891399.
      Citations: 51     Fields:    Translation:HumansCellsPHPublic Health
    71. Kow CS, Hasan SS. Montelukast in children with allergic rhinitis amid COVID-19 pandemic. Acta Paediatr. 2020 10; 109(10):2151. PMID: 32686128.
      Citations:    Fields:    Translation:HumansPHPublic Health
    72. Kow CS, Hasan SS. Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic. J Formos Med Assoc. 2021 01; 120(1 Pt 3):772-773. PMID: 32798030.
      Citations:    Fields:    Translation:HumansPHPublic Health
    73. Kow CS, Zaihan AF, Hasan SS. Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2020 12; 29(12):105222. PMID: 32891494.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    74. Kow CS, Sunter W, Bain A, Zaidi STR, Hasan SS. Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide. Am J Cardiovasc Drugs. 2020 Aug; 20(4):301-309. PMID: 32458370.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    75. Kow CS, Capstick T, Zaidi STR, Hasan SS. Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients. Eur J Hosp Pharm. 2021 01; 28(1):42-46. PMID: 32737069.
      Citations: 1     Translation:Humans
    76. Kow CS, Thiruchelvam K, Hasan SS. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev Cardiovasc Ther. 2020 Aug; 18(8):475-485. PMID: 32700573.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    77. Zaidi STR, Hasan SS. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm. 2021 01; 17(1):1832-1837. PMID: 33317761.
      Citations: 6     Fields:    Translation:Humans
    78. Kow CS, Hasan SS. Role of frailty in COVID-19 patients. Intensive Care Med. 2020 10; 46(10):1956-1957. PMID: 32638046.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    79. Kow CS, Hasan SS. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury. J Am Soc Nephrol. 2020 08; 31(8):1917-1918. PMID: 32639940.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    80. Kow CS, Hasan SS. Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease? J Med Virol. 2021 01; 93(1):92-93. PMID: 32519764.
      Citations: 1     Fields:    Translation:Humans
    81. Kow CS, Hasan SS. Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2020 09; 8(5):900-901. PMID: 32561464.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    82. Kow CS, Hasan SS. Metformin use amid coronavirus disease 2019 pandemic. J Med Virol. 2020 11; 92(11):2401-2402. PMID: 32470199.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    83. Kow CS, Hadi MA, Hasan SS. Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6). PMID: 32492809.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    84. Kow CS, Zaidi STR, Hasan SS. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221. PMID: 32281055.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    85. Hasan SS, Capstick T, Zaidi STR, Kow CS, Merchant HA. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045. PMID: 32843175.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    86. Kow CS, Hasan SS. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020 10; 48(5):805-806. PMID: 32388676.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    87. Hasan SS, Kow CS, Zaidi STR. Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? Res Social Adm Pharm. 2021 02; 17(2):456-459. PMID: 32387229.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    Hasan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (291)
    Explore
    _
    Co-Authors (44)
    Explore
    _
    Similar People (60)
    Explore
    _